<DOC>
	<DOCNO>NCT00044551</DOCNO>
	<brief_summary>Almost two-thirds lymphoma case Non-Hodgkin 's Lymphomas ( NHL ) . NHL malignant process affect lymphoid cell find lymph node extranodally . Incidence mortality rate NHL high developed country . While many patient aggressive NHL curable initial anthracycline-containing regimen , majority patient relapse prove refractory initial therapy . The prognosis patient disease recurrence follow multidrug regimen also limit . The current protocol design test safety efficacy BAY 59-8862 patient Aggressive Refractory Non-Hodgkin 's Lymphoma .</brief_summary>
	<brief_title>Evaluation Bay 59-8862 Patients With Aggressive , Refractory Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Taxane</mesh_term>
	<criteria>Measurable disease define presence least one measurable lesion Failed least one prior therapy achieve remission progress relapse within 6 month therapy Life expectancy least 12 week Adequate bone marrow , liver kidney function Excluded medical condition like : preexisting neuropathy , active heart diseases ischemia , serious infection , HIV infection , chronic hepatitis B C , seizures , hypersensitivity taxanes , organ transplant , previous cancer Excluded therapy medication , previous concomitant : anticancer chemotherapy immunotherapy study within 4 week prior study entry ; two prior anticancer chemotherapy regimens ; radiotherapy study within 4 week prior study entry ; bone marrow transplant Others : pregnant breastfeeding patient ; men woman enrol trial must use adequate barrier birth control measure course trial ; substance abuse , medical , psychological social condition may interfere patient 's participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Taxane</keyword>
	<keyword>Lymphoma</keyword>
	<keyword>Non-Hodgkin 's Lymphoma</keyword>
</DOC>